Correlation of Perfusion MRI and 18F-FDG PET Imaging Biomarkers for Monitoring Regorafenib Therapy in Experimental Colon Carcinomas with Immunohistochemical Validation-Reference-Cited by-同舟云学术

Correlation of Perfusion MRI and 18F-FDG PET Imaging Biomarkers for Monitoring Regorafenib Therapy in Experimental Colon Carcinomas with Immunohistochemical Validation

Published:2015-02-10 Issue:2 Volume:10 Page:e0115543
ISSN:1932-6203
Container-title:PLOS ONE
language:en
Short-container-title:PLoS ONE

Author:

Eschbach Ralf S.,Fendler Wolfgang P.,Kazmierczak Philipp M.,Hacker Marcus,Rominger Axel,Carlsen Janette,Hirner-Eppeneder Heidrun,Schuster Jessica,Moser Matthias,Havla Lukas,Schneider Moritz J.,Ingrisch Michael,Spaeth Lukas,Reiser Maximilian F.,Nikolaou Konstantin,Cyran Clemens C.

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference49 articles.

1. Anti-angiogenic therapies for metastatic colorectal cancer: current and future perspectives;I Marques;World J Gastroenterol,2013

2. New molecular targeting drugs for metastatic colorectal cancer;Y Komatsu;Nihon Rinsho,2014

3. Phase II clinical trial of sorafenib in metastatic medullary thyroid cancer;ET Lam;J Clin Oncol,2010

4. mTOR inhibitors in breast cancer: a systematic review;F Zagouri;Gynecol Oncol,2012

5. Novel agents and approaches for advanced renal cell carcinoma;R Figlin;J Urol,2012

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Useful Parameters in Dynamic Contrast-enhanced Ultrasonography for Identifying Early Response to Chemotherapy in a Rat Liver Tumor Model;Journal of Clinical Imaging Science;2021-03-15

2. Imaging and clinical correlates with regorafenib in metastatic colorectal cancer;Cancer Treatment Reviews;2020-06

3. Texture in the monitoring of regorafenib therapy in patients with colorectal liver metastases;Acta Radiologica;2019-01-06

4. Dynamic contrast-enhanced computed tomography as a potential biomarker in patients with metastatic colorectal cancer treated with regorafenib;Acta Radiologica;2018-10-22

5. Dynamic contrast-enhanced ultrasonography (D-CEUS) for the early prediction of bevacizumab efficacy in patients with metastatic colorectal cancer;European Radiology;2018-02-07